{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:19:42Z","timestamp":1790727582893,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019014","name":"Chengdu Science and Technology Program","doi-asserted-by":"publisher","award":["2024-YF05-00039-SN"],"award-info":[{"award-number":["2024-YF05-00039-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmc.2026.118551","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:11:48Z","timestamp":1767629508000},"page":"118551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel quinolinone derivatives as DprE1 inhibitors against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"134","author":[{"given":"Guoquan","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10481","key":"10.1016\/j.bmc.2026.118551_bb0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","volume":"405","author":"Trajman","year":"2025","journal-title":"Tuberculosis, Lancet"},{"key":"10.1016\/j.bmc.2026.118551_bb0010","first-page":"2024","author":"WHO","year":"2024","journal-title":"Global tuberculosis report"},{"key":"10.1016\/j.bmc.2026.118551_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130156","article-title":"Discovery of 1,3-disubstituted pyrazole derivatives as Mycobacterium tuberculosis inhibitors","volume":"121","author":"Wan","year":"2025","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"10.1016\/j.bmc.2026.118551_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117531","article-title":"Discovery of ultra short \u03b2-peptoids with selective activity against drug-resistant Mycobacterium tuberculosis","volume":"290","author":"Kauffman","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118551_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117148","article-title":"Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis","volume":"283","author":"Zhang","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118551_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","article-title":"Recent advances of imidazole-containing derivatives as anti tubercular agents","volume":"150","author":"Fan","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118551_bb0035","doi-asserted-by":"crossref","first-page":"1800934","DOI":"10.1183\/13993003.00934-2018","article-title":"Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review","volume":"52","author":"Emanuele","year":"2018","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.bmc.2026.118551_bb0040","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study, the lancet","volume":"4","author":"Brigitta","year":"2023","journal-title":"Microbe"},{"issue":"3\u20134","key":"10.1016\/j.bmc.2026.118551_bb0045","first-page":"112","article-title":"Extensively drug-resistant tuberculosis (XDR-TB)-inhibitors to overcome the scourge of drug-resistant tuberculosis: a perspective, reviews and advances","volume":"10","author":"Harun","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2026.118551_bb0050","article-title":"Structure-activity relationship mediated molecular insights of DprE1 inhibitors: a comprehensive review","author":"Swagatika","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.bmc.2026.118551_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13065-018-0441-2","article-title":"Decaprenyl-phosphoryl-ribose 2\u2032-epimerase (DprE1): challenging target for antitubercular drug discovery","volume":"12","author":"Gawad","year":"2018","journal-title":"Chemistry Central Journal"},{"issue":"7","key":"10.1016\/j.bmc.2026.118551_bb0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/acschembio.5b00237","article-title":"DprE1 is a vulnerable tuberculosis drug target due to its Cell Wall localization","volume":"10","author":"Miroslav","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"20","key":"10.1016\/j.bmc.2026.118551_bb0065","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1007\/s00253-013-5218-x","article-title":"The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis","volume":"97","author":"Riccardi","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"10.1016\/j.bmc.2026.118551_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103987","article-title":"Recent advances in the development of DprE1 inhibitors using AI\/CADD approaches","volume":"29","author":"Chen","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118551_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116785","article-title":"Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment","volume":"277","author":"Wei","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118551_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116559","article-title":"DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs","volume":"274","author":"Paoli-Lombardo","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118551_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ph18010070","article-title":"Targeting the Heart of Mycobacterium: Advances in Anti-Tubercular Agents Disrupting Cell Wall Biosynthesis","author":"Diab","year":"2025","journal-title":"Pharmaceuticals [Online]"},{"issue":"3","key":"10.1016\/j.bmc.2026.118551_bb0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"Embo Molecular Medicine"},{"issue":"16","key":"10.1016\/j.bmc.2026.118551_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 inhibitors: enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"Chemmedchem"},{"issue":"19","key":"10.1016\/j.bmc.2026.118551_bb0100","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/acs.jmedchem.8b00281","article-title":"Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis","volume":"61","author":"Chikhale","year":"2018","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2026.118551_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.drudis.2016.09.014","article-title":"Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors","volume":"22","author":"J\u00e9r\u00e9mie","year":"2017","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bmc.2026.118551_bb0110","first-page":"275","article-title":"Approaches to mitigate the risk of serious adverse reactions in covalent drug design","volume":"16","author":"Thomas","year":"2020","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"10.1016\/j.bmc.2026.118551_bb0115","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm5002937","article-title":"Discovery of Pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity","volume":"57","author":"Panda","year":"2014","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2026.118551_bb0120","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1021\/acsomega.1c01314","article-title":"Chemical space exploration of DprE1 inhibitors using Chemoinformatics and artificial intelligence, ACS","volume":"6","author":"Sonali","year":"2021","journal-title":"Omega"},{"issue":"6","key":"10.1016\/j.bmc.2026.118551_bb0125","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41401-021-00779-1","article-title":"Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening","volume":"43","author":"Hu","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.bmc.2026.118551_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel Carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.bmc.2026.118551_bb0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13063-024-07912-5","article-title":"Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b\/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy","volume":"25","author":"Dawson","year":"2024","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.bmc.2026.118551_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill Mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2026.118551_bb0145","series-title":"Quinolinone derivative as well as preparation method and application thereof","volume":"CN116102537","author":"Sichuan University","year":"2023"},{"issue":"10","key":"10.1016\/j.bmc.2026.118551_bb0150","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1021\/acs.orglett.1c01248","article-title":"Synthesis and Structural Revision of Glyphaeaside C","volume":"23","author":"Byatt","year":"2021","journal-title":"Org Lett"},{"issue":"5","key":"10.1016\/j.bmc.2026.118551_bb0155","article-title":"Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis, microbiology","volume":"11","author":"Xiang","year":"2023","journal-title":"Spectrum"},{"issue":"23","key":"10.1016\/j.bmc.2026.118551_bb0160","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118551_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008452","article-title":"Protein kinases PknA and PknB independently and coordinately regulate essential Mycobacterium tuberculosis physiologies and antimicrobial susceptibility","volume":"16","author":"Zeng","year":"2020","journal-title":"PLoS Pathog"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:32:58Z","timestamp":1769117578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S0968089626000076"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118551","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel quinolinone derivatives as DprE1 inhibitors against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118551"}}